NasdaqGM - Delayed Quote USD

Acrivon Therapeutics, Inc. (ACRV)

1.2000
-0.0700
(-5.51%)
At close: June 13 at 4:00:01 PM EDT
1.2000
0.00
(0.00%)
After hours: June 13 at 5:54:40 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -19.68M

Q2'24

Q3'24

Q4'24

Q1'25

-20M
-15M
-10M
-5M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

6.00
11.33 Average
1.2000 Current
19.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 6666
Avg. Estimate -0.58-0.58-2.24-2.37
Low Estimate -0.71-0.76-2.9-3.5
High Estimate -0.47-0.44-1.73-1.72
Year Ago EPS -0.52-0.59-2.38-2.24

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 9999
Avg. Estimate ----129.33k1.47M
Low Estimate --------
High Estimate ----1.16M10.5M
Year Ago Sales ------129.33k
Sales Growth (year/est) 0.00%0.00%0.00%1,034.39%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -0.57-0.59-0.7-0.65
EPS Actual -0.52-0.59-0.54-0.51
Difference 0.0500.160.14
Surprise % 8.77%0.24%23.30%21.05%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.58-0.58-2.24-2.37
7 Days Ago -0.65-0.61-2.54-2.38
30 Days Ago -0.64-0.67-2.64-2.5
60 Days Ago -0.75-0.79-2.96-2.79
90 Days Ago -0.8-0.88-2.91-2.79

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 2--22
Up Last 30 Days 1--32
Down Last 7 Days --21--
Down Last 30 Days --1----

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ACRV -12.18%1.69%6.02%-5.89%
S&P 500 13.13%2.43%7.54%14.06%

Upgrades & Downgrades

Downgrade Jones Trading: Buy to Hold 5/16/2025
Maintains Oppenheimer: Outperform to Outperform 5/15/2025
Reiterates HC Wainwright & Co.: Buy to Buy 3/28/2025
Reiterates Cantor Fitzgerald: Overweight to Overweight 3/26/2025
Reiterates Citizens Capital Markets: Market Outperform to Market Outperform 3/26/2025
Maintains HC Wainwright & Co.: Buy to Buy 3/26/2025

Related Tickers